Scinovex
article Open AccessTop 1% cited

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

JNCI Journal of the National Cancer Institute · 2009 · Vol. 101(10) · pp. 736–750
Maggie C.U. CheangStephen ChiaDavid VoducDongxia GaoSamuel LeungJacqueline SniderMark WatsonSherri R. DaviesPhilip S. BernardJoel S. ParkerCharles M. PerouMatthew J. EllisTorsten O. Nielsen

Abstract

Expression of ER, progesterone receptor, and HER2 proteins and the Ki67 index appear to distinguish luminal A from luminal B breast cancer subtypes.

Breast Cancer Treatment StudiesCancer Cells and MetastasisHER2/EGFR in Cancer ResearchBreast cancerImmunohistochemistryMedicineEstrogen receptorTissue microarrayOncologyInternal medicineProliferation indexProliferative indexCancer

MeSH terms

AdultAgedBreast NeoplasmsHumansMiddle AgedPrognosisReceptors, EstrogenReceptors, ProgesteroneCohort StudiesGene Expression Regulation, NeoplasticTreatment OutcomeReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesKi-67 AntigenGene Expression Profiling
Citations
2,199
FWCI
45.07
field-weighted impact
References
71
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.